PP
CCXI

PDT Partners’s ChemoCentryx, Inc. CCXI Stock Holding History

PDT Partners’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,700
Closed -$86K – 782
2019
Q3 		$86K Sell
12,700
-35,506
-74% -$266K 0.01% 440
2019
Q2 		$448K Buy
48,206
+28,386
+143% +$329K 0.03% 313
2019
Q1 		$275K Buy
19,820
+351
+2% +$4.01K 0.02% 363
2018
Q4 		$212K Buy
19,469
+1,655
+9% +$17.5K 0.01% 399
2018
Q3 		$225K Buy
+17,814
New +$215K 0.01% 423
2013
Q4 		– Sell
-28,007
Closed -$156K – 1254
2013
Q3 		$156K Buy
28,007
+11,947
+74% +$129K ﹤0.01% 1422
2013
Q2 		$227K Buy
+16,060
New +$208K 0.01% 1337

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PDT Partners's CCXI Position: Q4 2019 in Review

PDT Partners sold out of ChemoCentryx, Inc. (CCXI) in Q4 2019, closing a stake of 12,700 shares — an estimated $86K sold.

PDT Partners first reported a position in CCXI in Q2 2013 and held it in 7 quarters. The position peaked at $448K in Q2 2019. 126 funds tracked by Wall St. Rank hold CCXI as of Q4 2019.

  • PDT Partners reported no remaining ChemoCentryx, Inc. position as of Q4 2019 after selling out during the quarter.
  • PDT Partners sold 12,700 ChemoCentryx, Inc. shares in Q4 2019, an estimated $86K.
  • PDT Partners first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 7 quarters.
  • PDT Partners's ChemoCentryx, Inc. position peaked at $448K in Q2 2019.
  • 126 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2019.

Based on PDT Partners's 13F filing for Q4 2019, filed 14 Feb 2020.